Scholarlink

Background <p><i>SPTBN1</i> encodes βII-spectrin, a cytoskeletal protein essential for neuronal structure and function. Pathogenic variants in this gene cause a neurodevelopmental disorder known as DDISBA (Developmental Delay, Impaired Speech, and Behavioral Abnormalities). To date, reports of <i>SPTBN1</i>-related disorders in the Chinese population are notably limited.</p> Methods <p>Trio-based whole exome sequencing was performed to identify candidate variants, which were subsequently classified according to the ACMG classification guidelines following written informed consent. Structural modeling was subsequently conducted using AlphaFold and PyMOL to evaluate the variant’s impact on protein conformation.</p> Results <p>A Chinese male child presenting with global developmental delay, profound speech impairment, hypotonia, facial dysmorphism, and abnormal brain MRI findings was studied and reported. Trio-based whole exome sequencing identified a novel <i>de novo</i>, ‘likely pathogenic’, missense variant in <i>SPTBN1</i> (NM_003128.3: c.471&#xa0;C &gt; G, p.Phe157Leu; Chr2:54612331, GRCh38), located in the actin-binding CH1 domain. In silico analyses suggest this variant disrupts local protein stability through significant side-chain rearrangement (<i>S</i><sub><i>diff</i></sub>=12.75°), while maintaining overall backbone integrity (RMSD = 0.11 Å).</p> Conclusions <p>This study describes the first genetically confirmed case of DDISBA in a Chinese individual, expands the known phenotypic and genotypic spectrum of <i>SPTBN1</i>-related disorders and highlights the importance of variant type and population diversity in diagnosis. Structural modeling revealing significant side-chain rearrangement and increased steric hindrance suggests that local conformational disruption is a key pathogenic mechanism for the p.Phe157Leu variant.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Clinical characterization and structural modeling of a novel de novo SPTBN1 missense variant in a Chinese child

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月20日

查看全文
  • Junyu Wang,
  • Yu Zhang,
  • Shiqi Yang,
  • Jiangxi Xiao,
  • Huifang Yan,
  • Jingmin Wang

摘要

Background

SPTBN1 encodes βII-spectrin, a cytoskeletal protein essential for neuronal structure and function. Pathogenic variants in this gene cause a neurodevelopmental disorder known as DDISBA (Developmental Delay, Impaired Speech, and Behavioral Abnormalities). To date, reports of SPTBN1-related disorders in the Chinese population are notably limited.

Methods

Trio-based whole exome sequencing was performed to identify candidate variants, which were subsequently classified according to the ACMG classification guidelines following written informed consent. Structural modeling was subsequently conducted using AlphaFold and PyMOL to evaluate the variant’s impact on protein conformation.

Results

A Chinese male child presenting with global developmental delay, profound speech impairment, hypotonia, facial dysmorphism, and abnormal brain MRI findings was studied and reported. Trio-based whole exome sequencing identified a novel de novo, ‘likely pathogenic’, missense variant in SPTBN1 (NM_003128.3: c.471 C > G, p.Phe157Leu; Chr2:54612331, GRCh38), located in the actin-binding CH1 domain. In silico analyses suggest this variant disrupts local protein stability through significant side-chain rearrangement (Sdiff=12.75°), while maintaining overall backbone integrity (RMSD = 0.11 Å).

Conclusions

This study describes the first genetically confirmed case of DDISBA in a Chinese individual, expands the known phenotypic and genotypic spectrum of SPTBN1-related disorders and highlights the importance of variant type and population diversity in diagnosis. Structural modeling revealing significant side-chain rearrangement and increased steric hindrance suggests that local conformational disruption is a key pathogenic mechanism for the p.Phe157Leu variant.